Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Leases (2024 - 2025)

Historic Current Leases for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $1.4 million.

  • Kura Oncology's Current Leases fell 1549.38% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 1549.38%. This contributed to the annual value of $1.9 million for FY2024, which is N/A changed from last year.
  • Kura Oncology's Current Leases amounted to $1.4 million in Q3 2025, which was down 1549.38% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Current Leases ranged from a high of $1.9 million in Q1 2025 and a low of $1.4 million during Q1 2024